Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on September 10, 2026

12 hours ago

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment

Indeterminate GlobeNewswire

12 hours ago

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Indeterminate GlobeNewswire

12 hours ago

Long-Acting Oligonucleotide Development: Dosing, Yield and Stability Questions

Indeterminate GlobeNewswire

12 hours ago

Actithera significantly strengthens leadership team and Board as Company advances towards clinical development

Indeterminate GlobeNewswire

12 hours ago

Retail Customer Service Outsourcing Now Hinges on Peak-Season Resilience

Indeterminate GlobeNewswire

12 hours ago

Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program

Indeterminate GlobeNewswire

12 hours ago

Shock Top and Auntie Anne’s® Take Over Tailgate Season with the Return of Shock Top Twisted Pretzel Wheat and the Limited-Edition TWIST Vest

Indeterminate GlobeNewswire

12 hours ago

Grey Matters Closes First Tranche of $600,000 of its Equity and Convertible Debenture Private Placement

Indeterminate GlobeNewswire

12 hours ago

Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models

Indeterminate GlobeNewswire

12 hours ago

Nkarta to Participate in September Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference

Indeterminate GlobeNewswire

12 hours ago

CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health

Indeterminate GlobeNewswire

12 hours ago

Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

13 hours ago

Ethris and EIB sign €30M financing under HERA Invest to advance further clinical development of broad-spectrum nasal antiviral

Indeterminate GlobeNewswire

13 hours ago

Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes

Indeterminate GlobeNewswire

13 hours ago

Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

13 hours ago

Kestra Names Daniel Finney Vice President of Research & Development

Indeterminate GlobeNewswire

13 hours ago

Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies

Indeterminate GlobeNewswire

13 hours ago

Syngenta und Amoéba schließen exklusiven europäischen Vertriebsvertrag, um Getreideerzeugern ein wegweisendes Biofungizid bereitzustellen

Indeterminate GlobeNewswire

13 hours ago

Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers

Indeterminate GlobeNewswire